• Je něco špatně v tomto záznamu ?

The coincidence of low vitamin K status and high expression of growth differentiation factor 15 may indicate increased mortality risk in stable coronary heart disease patients

O. Mayer, J. Bruthans, J. Seidlerová, P. Karnosová, M. Mateřánková, J. Gelžinský, M. Rychecká, J. Opatrný, P. Wohlfahrt, R. Kučera, L. Trefil, R. Cífková, J. Filipovský, C. Vermeer

. 2021 ; 31 (2) : 540-551. [pub] 20200922

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21011507

Grantová podpora
NV17-29520A MZ0 CEP - Centrální evidence projektů

BACKGROUND AND AIMS: Matrix Gla protein (MGP) is a natural inhibitor of vascular calcification critically dependent on circulating vitamin K status. Growth differentiation factor 15 (GDF-15) is a regulatory cytokine mainly of the inflammatory and angiogenesis pathways, but potentially also involved in bone mineralization. We sought to determine whether these two circulating biomarkers jointly influenced morbidity and mortality risk in patients with chronic coronary heart disease (CHD). METHODS AND RESULTS: 894 patients ≥6 months after myocardial infarction and/or coronary revascularization at baseline were followed in a prospective study. All-cause and cardiovascular mortality, non-fatal cardiovascular events (myocardial infarction, stroke, any revascularization), and hospitalization for heart failure (HF) were followed as outcomes. Desphospho-uncarboxylated MGP (dp-ucMGP) was used as a biomarker of vitamin K status. Both, increased concentrations of dp-ucMGP (≥884 pmol/L) and GDF-15 (≥1339 pg/mL) were identified as independent predictors of 5-year all-cause or cardiovascular mortality. However, their coincidence further increased mortality risk. The highest risk was observed in patients with high dp-ucMGP plus high GDF-15, not only when compared with those with "normal" concentrations of both biomarkers [HR 5.51 (95% CI 2.91-10.44), p < 0.0001 and 6.79 (95% CI 3.06-15.08), p < 0.0001 for all-cause and cardiovascular mortality, respectively], but even when compared with patients with only one factor increased. This pattern was less convincing with non-fatal cardiovascular events or hospitalization for HF. CONCLUSIONS: The individual coincidence of low vitamin K status (high dp-ucMGP) and high GDF-15 expression predicts poor survival of stable CHD patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21011507
003      
CZ-PrNML
005      
20250325142845.0
007      
ta
008      
210420s2021 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.numecd.2020.09.015 $2 doi
035    __
$a (PubMed)33257192
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Mayer, Otto $u 2nd Department of Internal Medicine, Medical Faculty of Charles University and University Hospital, Pilsen, Czech Republic; Biomedical Center, Medical Faculty of Charles University, Pilsen, Czech Republic. Electronic address: mayero@fnplzen.cz
245    14
$a The coincidence of low vitamin K status and high expression of growth differentiation factor 15 may indicate increased mortality risk in stable coronary heart disease patients / $c O. Mayer, J. Bruthans, J. Seidlerová, P. Karnosová, M. Mateřánková, J. Gelžinský, M. Rychecká, J. Opatrný, P. Wohlfahrt, R. Kučera, L. Trefil, R. Cífková, J. Filipovský, C. Vermeer
520    9_
$a BACKGROUND AND AIMS: Matrix Gla protein (MGP) is a natural inhibitor of vascular calcification critically dependent on circulating vitamin K status. Growth differentiation factor 15 (GDF-15) is a regulatory cytokine mainly of the inflammatory and angiogenesis pathways, but potentially also involved in bone mineralization. We sought to determine whether these two circulating biomarkers jointly influenced morbidity and mortality risk in patients with chronic coronary heart disease (CHD). METHODS AND RESULTS: 894 patients ≥6 months after myocardial infarction and/or coronary revascularization at baseline were followed in a prospective study. All-cause and cardiovascular mortality, non-fatal cardiovascular events (myocardial infarction, stroke, any revascularization), and hospitalization for heart failure (HF) were followed as outcomes. Desphospho-uncarboxylated MGP (dp-ucMGP) was used as a biomarker of vitamin K status. Both, increased concentrations of dp-ucMGP (≥884 pmol/L) and GDF-15 (≥1339 pg/mL) were identified as independent predictors of 5-year all-cause or cardiovascular mortality. However, their coincidence further increased mortality risk. The highest risk was observed in patients with high dp-ucMGP plus high GDF-15, not only when compared with those with "normal" concentrations of both biomarkers [HR 5.51 (95% CI 2.91-10.44), p < 0.0001 and 6.79 (95% CI 3.06-15.08), p < 0.0001 for all-cause and cardiovascular mortality, respectively], but even when compared with patients with only one factor increased. This pattern was less convincing with non-fatal cardiovascular events or hospitalization for HF. CONCLUSIONS: The individual coincidence of low vitamin K status (high dp-ucMGP) and high GDF-15 expression predicts poor survival of stable CHD patients.
650    _2
$a senioři $7 D000368
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a proteiny vázající vápník $x krev $7 D002135
650    _2
$a chronická nemoc $7 D002908
650    _2
$a koronární nemoc $x krev $x diagnóza $x mortalita $x terapie $7 D003327
650    _2
$a průřezové studie $7 D003430
650    _2
$a extracelulární matrix - proteiny $x krev $7 D016326
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a růstový diferenciační faktor 15 $x krev $7 D055436
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    _2
$a prospektivní studie $7 D011446
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a časové faktory $7 D013997
650    _2
$a up regulace $7 D015854
650    _2
$a nedostatek vitaminu D $x krev $x diagnóza $x mortalita $7 D014808
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bruthans, Jan $u 2nd Department of Internal Medicine, Medical Faculty of Charles University and University Hospital, Pilsen, Czech Republic; Department of Immunodiagnostics, University Hospital, Pilsen, Czech Republic
700    1_
$a Seidlerová, Jitka $u 2nd Department of Internal Medicine, Medical Faculty of Charles University and University Hospital, Pilsen, Czech Republic; Biomedical Center, Medical Faculty of Charles University, Pilsen, Czech Republic
700    1_
$a Karnosová, Petra, $u 2nd Department of Internal Medicine, Medical Faculty of Charles University and University Hospital, Pilsen, Czech Republic; Biomedical Center, Medical Faculty of Charles University, Pilsen, Czech Republic $d 1985- $7 xx0330667
700    1_
$a Mateřánková, Markéta $u 2nd Department of Internal Medicine, Medical Faculty of Charles University and University Hospital, Pilsen, Czech Republic; Biomedical Center, Medical Faculty of Charles University, Pilsen, Czech Republic
700    1_
$a Gelžinský, Julius $u 2nd Department of Internal Medicine, Medical Faculty of Charles University and University Hospital, Pilsen, Czech Republic; Biomedical Center, Medical Faculty of Charles University, Pilsen, Czech Republic
700    1_
$a Rychecká, Martina $u 2nd Department of Internal Medicine, Medical Faculty of Charles University and University Hospital, Pilsen, Czech Republic
700    1_
$a Opatrný, Jan $u Department of Cardiology, Medical Faculty of Charles University and University Hospital, Pilsen, Czech Republic
700    1_
$a Wohlfahrt, Peter $u Centre for Cardiovascular Prevention, First Faculty of Medicine, Charles, University and Thomayer Hospital, Prague, Czech Republic
700    1_
$a Kučera, Radek $u Department of Immunodiagnostics, University Hospital, Pilsen, Czech Republic
700    1_
$a Trefil, Ladislav $u Department of Clinical Biochemistry and Hematology, University Hospital, Pilsen, Czech Republic
700    1_
$a Cífková, Renata $u Centre for Cardiovascular Prevention, First Faculty of Medicine, Charles, University and Thomayer Hospital, Prague, Czech Republic
700    1_
$a Filipovský, Jan $u 2nd Department of Internal Medicine, Medical Faculty of Charles University and University Hospital, Pilsen, Czech Republic; Biomedical Center, Medical Faculty of Charles University, Pilsen, Czech Republic
700    1_
$a Vermeer, Cees $u Cardiovascular Research Institute CARIM, Maastricht University, the Netherlands
773    0_
$w MED00003575 $t NMCD. Nutrition Metabolism and Cardiovascular Diseases $x 1590-3729 $g Roč. 31, č. 2 (2021), s. 540-551
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33257192 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20250325142845 $b ABA008
999    __
$a ok $b bmc $g 1650014 $s 1131886
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 31 $c 2 $d 540-551 $e 20200922 $i 1590-3729 $m NMCD. Nutrition Metabolism and Cardiovascular Diseases $n Nutr Metab Cardiovasc Dis $x MED00003575
GRA    __
$a NV17-29520A $p MZ0
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace